Flourish Expands with Keystone Clinical Acquisition

October 20, 2022
Flourish Research announces the acquisition of Keystone Clinical Studies, adding to the rapidly expanding Flourish enterprise. Keystone, which is in the greater Philadelphia area, is a leader in Alzheimer’s Disease and other CNS research and the addition of the site expands Flourish’s reach in these core areas of research. Read the full release.
Read More

Reinhold Schulz Named CEO

August 20, 2022
Reinhold Schulz has been named Chief Executive Officer of Flourish Research, a company designed to acquire, operate, and integrate the best clinical research sites in North America. Flourish operates large, best-in-class sites with experience in Phases I-IV and investigators with deep expertise in key therapeutic areas. Read the full release.
Read More